Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
Micheletti
Marie-Christine
MC
Chevallier
Thierry
T
D000368:Aged; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D016001:Confidence Intervals; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008535:Megestrol / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009649:Norpregnadienes / Q000008:administration & dosage / Q000009:adverse effects*; D009650:Norpregnanes / Q000008:administration & dosage / Q000009:adverse effects; D016017:Odds Ratio; D017698:Postmenopause; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000139:chemically induced*
D004967:Estrogens; D009649:Norpregnadienes; D009650:Norpregnanes; D011372:Progestins; C038501:nomegestrol acetate; D008535:Megestrol